Answers are grounded in this paper and cite their sources.
We found focal inflammation after discontinuation of OCR in 4 (9.8 %) of the RRMS patients, of which 1 was radiologically confirmed. Our observations highlight that recurrence of focal inflammation seems low but discontinuation may not be appropriate for everyone. Further larger studies are important to determine the immune reconstitution therapy potential of OCR.
No takes yet. Share an insight, caveat, or question.
Coerver et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: